Icon

DEPAKOTE (nda018723)- (EQ 250MG VALPROIC ACID,EQ 500MG VALPROIC ACID,EQ 125MG VALPROIC ACID)

DIVALPROEX SODIUM ABBVIE
EQ 250MG VALPROIC ACID,EQ 500MG VALPROIC ACID,EQ 125MG VALPROIC ACID
Yes No
2008-Jul-29 Expired
None None
None No
Depakote is an anti-epileptic drug indicated for: • Treatment of manic episodes associated with bipolar disorder • Monotherapy and adjunctive therapy of complex partial seizures and simple and complex absence seizures; adjunctive therapy in patients with multiple seizure types that include absence seizures • Prophylaxis of migraine headaches.
13 0 8
Total Other Developers None
Drugs with Suitability No
EQ 250MG VALPROIC ACID ** ** Up 4 1
EQ 500MG VALPROIC ACID ** ** Up - 5
EQ 125MG VALPROIC ACID ** ** - - 5
NDA Sales Available Total Generic Sales Available
Yes 6
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ****** *** *** ***** ************ ******* *********** ****** **. ***, *** *** ***, ******* ***** *. *. **. ** *******-*******, ******-****** *********, *********, ******* ******, ***** (***) ***
****** ****** ***** **** ******-***** ************, *** *********** ***** **** *** *, ********, ********* (**) *****-****, ****** ****** (***) ***
****** *** ***** **** *** ************** ********** ******* *********** *****-****** *******, *****, ******* ******, ***** (***) ***
****** ** ****** **** *** **. *****'* ************ ******* *********** ****** **. **, ** ****, ** **** & ** ****, ********** ******* *** ******, *******-********** ********,, *******-**********, ********* ******, ***** (***) ***
****** ***** ***** ******* *********** **** **. **-*, ***** *-*, ***** ********** ****, *****, ********, *** ******, ***** (***) ***
****** ****** ****** ****** *************** ******* ******* *********** **** **.** (****) *** ** (****), ****** ********** ****, ***************, *************, ************, ***** **** ******, ***** (***) ***
****** ******* **** *** ******* ************ ******* *********** *-**, ** & *-**, ********** ****, ****** ****, *********, ***** ******* ******, ***** (***) ***
****** ********* ****** *** ********* ****** ******* *********** ****-***, **. **.*** & ***, **********, ********** ******, *******-********** ********, *******, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.